Literature DB >> 24048169

Human milk oligosaccharides protect against enteropathogenic Escherichia coli attachment in vitro and EPEC colonization in suckling mice.

Carolin F Manthey1, Chloe A Autran, Lars Eckmann, Lars Bode.   

Abstract

Breast-feeding reduces the risk of enteric bacterial infections in newborns in part because of human milk oligosaccharides (HMOs), complex glycans that are present in human milk, but not in infant formula. Enteropathogenic Escherichia coli (EPEC) are attaching/effacing pathogens that cause serious diarrheal illness with potentially high mortality in infants. We isolated HMOs from pooled human milk and found that they significantly reduce EPEC attachment to cultured epithelial cells. In suckling mice, administration of HMOs significantly reduced colonization with EPEC compared with untreated controls. These data suggest an essential role for HMOs in the prevention of EPEC infections in human infants.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24048169      PMCID: PMC8865036          DOI: 10.1097/MPG.0000000000000172

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  13 in total

1.  The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats.

Authors:  Evelyn Jantscher-Krenn; Monica Zherebtsov; Caroline Nissan; Kerstin Goth; Yigit S Guner; Natasha Naidu; Biswa Choudhury; Anatoly V Grishin; Henri R Ford; Lars Bode
Journal:  Gut       Date:  2011-12-03       Impact factor: 23.059

Review 2.  Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements.

Authors:  G Frankel; A D Phillips; I Rosenshine; G Dougan; J B Kaper; S Knutton
Journal:  Mol Microbiol       Date:  1998-12       Impact factor: 3.501

Review 3.  Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.

Authors:  Alexander R C Wong; Jaclyn S Pearson; Michael D Bright; Diana Munera; Keith S Robinson; Sau Fung Lee; Gad Frankel; Elizabeth L Hartland
Journal:  Mol Microbiol       Date:  2011-05-05       Impact factor: 3.501

4.  WHO estimates of the causes of death in children.

Authors:  Jennifer Bryce; Cynthia Boschi-Pinto; Kenji Shibuya; Robert E Black
Journal:  Lancet       Date:  2005 Mar 26-Apr 1       Impact factor: 79.321

5.  Mouse model of enteropathogenic Escherichia coli infection.

Authors:  Suzana D Savkovic; Jennilee Villanueva; Jerrold R Turner; Kristina A Matkowskyj; Gail Hecht
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

6.  Comparison of colonization dynamics and pathology of mice infected with enteropathogenic Escherichia coli, enterohaemorrhagic E. coli and Citrobacter rodentium.

Authors:  Rosanna Mundy; Francis Girard; Anthony J FitzGerald; Gad Frankel
Journal:  FEMS Microbiol Lett       Date:  2006-10-10       Impact factor: 2.742

Review 7.  Human milk oligosaccharides: every baby needs a sugar mama.

Authors:  Lars Bode
Journal:  Glycobiology       Date:  2012-04-18       Impact factor: 4.313

8.  Intimin from enteropathogenic Escherichia coli restores murine virulence to a Citrobacter rodentium eaeA mutant: induction of an immunoglobulin A response to intimin and EspB.

Authors:  G Frankel; A D Phillips; M Novakova; H Field; D C Candy; D B Schauer; G Douce; G Dougan
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

9.  The bundlin pilin protein of enteropathogenic Escherichia coli is an N-acetyllactosamine-specific lectin.

Authors:  Romney M Hyland; Jiangxiao Sun; Thomas P Griener; George L Mulvey; John S Klassen; Michael S Donnenberg; Glen D Armstrong
Journal:  Cell Microbiol       Date:  2007-08-14       Impact factor: 3.715

10.  Hospitalization and mortality among primarily nonbreastfed children during a large outbreak of diarrhea and malnutrition in Botswana, 2006.

Authors:  Tracy L Creek; Andrea Kim; Lydia Lu; Anna Bowen; Japhter Masunge; Wences Arvelo; Molly Smit; Ondrej Mach; Keitumetse Legwaila; Catherine Motswere; Laurel Zaks; Thomas Finkbeiner; Laura Povinelli; Maruping Maruping; Gibson Ngwaru; Goitebetswe Tebele; Cheryl Bopp; Nancy Puhr; Stephanie P Johnston; Alexandre J Dasilva; Caryn Bern; R S Beard; Margarett K Davis
Journal:  J Acquir Immune Defic Syndr       Date:  2010-01       Impact factor: 3.731

View more
  32 in total

Review 1.  Enteropathogenic Escherichia coli: foe or innocent bystander?

Authors:  J Hu; A G Torres
Journal:  Clin Microbiol Infect       Date:  2015-01-28       Impact factor: 8.067

Review 2.  Probiotics and necrotizing enterocolitis.

Authors:  Josef Neu
Journal:  Clin Perinatol       Date:  2014-09-30       Impact factor: 3.430

Review 3.  Prebiotics: tools to manipulate the gut microbiome and metabolome.

Authors:  Fatima Enam; Thomas J Mansell
Journal:  J Ind Microbiol Biotechnol       Date:  2019-06-14       Impact factor: 3.346

Review 4.  The impact of the milk glycobiome on the neonate gut microbiota.

Authors:  Alline R Pacheco; Daniela Barile; Mark A Underwood; David A Mills
Journal:  Annu Rev Anim Biosci       Date:  2014-11-05       Impact factor: 8.923

Review 5.  Building Robust Assemblages of Bacteria in the Human Gut in Early Life.

Authors:  Gerald W Tannock
Journal:  Appl Environ Microbiol       Date:  2021-09-01       Impact factor: 4.792

6.  Human Milk Oligosaccharides Impact Cellular and Inflammatory Gene Expression and Immune Response.

Authors:  Fernanda Rosa; Ashok K Sharma; Manoj Gurung; David Casero; Katelin Matazel; Lars Bode; Christy Simecka; Ahmed A Elolimy; Patricia Tripp; Christopher Randolph; Timothy W Hand; Keith D Williams; Tanya LeRoith; Laxmi Yeruva
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

Review 7.  The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota.

Authors:  Christian Milani; Sabrina Duranti; Francesca Bottacini; Eoghan Casey; Francesca Turroni; Jennifer Mahony; Clara Belzer; Susana Delgado Palacio; Silvia Arboleya Montes; Leonardo Mancabelli; Gabriele Andrea Lugli; Juan Miguel Rodriguez; Lars Bode; Willem de Vos; Miguel Gueimonde; Abelardo Margolles; Douwe van Sinderen; Marco Ventura
Journal:  Microbiol Mol Biol Rev       Date:  2017-11-08       Impact factor: 11.056

8.  Effect of a novel animal milk oligosaccharide biosimilar on the gut microbial communities and metabolites of in vitro incubations using feline and canine fecal inocula.

Authors:  Patrícia M Oba; Sara Vidal; Romain Wyss; Yong Miao; Yemi Adesokan; Kelly S Swanson
Journal:  J Anim Sci       Date:  2020-09-01       Impact factor: 3.159

9.  Effect of a novel animal milk oligosaccharide biosimilar on macronutrient digestibility and gastrointestinal tolerance, fecal metabolites, and fecal microbiota of healthy adult cats.

Authors:  Patrícia M Oba; Anne H Lee; Sara Vidal; Romain Wyss; Yong Miao; Yemi Adesokan; Kelly S Swanson
Journal:  J Anim Sci       Date:  2021-01-01       Impact factor: 3.159

Review 10.  Gold standard for nutrition: a review of human milk oligosaccharide and its effects on infant gut microbiota.

Authors:  Shunhao Zhang; Tianle Li; Jing Xie; Demao Zhang; Caixia Pi; Lingyun Zhou; Wenbin Yang
Journal:  Microb Cell Fact       Date:  2021-05-28       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.